SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Vector1 who wrote (1017)4/22/2000 12:06:00 PM
From: Tom Johnson  Respond to of 52153
 
The next big thing for osteoarthritis will be Dimethaid (DMX.T).Finished phase three trials,(No serious side effects!), partnered with Johnson & Johnson, approved in the UK, awaiting final approval from HPB (Canada) and FDA. Already purchased and functioning manufacturing facility,plus interesting pipeline. Check it out at www.dimethaid.com